Anti-DEI group targets Geisinger College of Health Sciences over program
SCRANTON — A national anti-DEI group has targeted the Geisinger College of Health Sciences with recent filings of discrimination complaints.
Virginia-based Do No Harm purported in news releases in March and June that it filed separate complaints with two federal agencies against the college, citing as discriminatory its federally funded Center of Excellence for Diversity and Inclusion and a summer program that aimed to help students from Black, Hispanic or Native American communities that are underrepresented in the medical field transition into medical school.
The Do No Harm discrimination complaints come amid President Donald Trump's efforts to dismantle DEI, or diversity, equity and inclusion, programs in the public and private sectors. Trump issued executive orders in the first week of his second term targeting DEI initiatives.
'Geisinger College of Health Sciences did a thorough review of our programs after the presidential executive orders were issued to ensure compliance. The pre-matriculation program referenced in the (Do No Harm) complaint ended in 2024 and is no longer active,' Geisinger CHS said in a statement.
Do No Harm is labeled by the Southern Poverty Law Center as an 'anti-LGBTQ+ hate group.' Critics of the SPLC say it's politically biased and its definition of hate group is overly broad.
Do No Harm first filed a complaint with the U.S. Department of Health and Human Services on March 19 against Geisinger CHS, according to a news release posted on the Do No Harm website. A member of Do No Harm then filed a similar complaint June 5 with the U.S. Department of Education, because Geisinger 'did not learn its lesson' from the initial complaint filed with HHS, the advocacy organization announced in another news release.
The Times-Tribune could not verify that the complaints were filed with both departments, and whether either agency investigated the allegations or took any actions. The U.S. Department of Health and Human Services and the U.S. Department of Education through separate representatives said they do not confirm the existence of complaints.
Do No Harm, established in April 2022, claims it has 17,000 members, including doctors, nurses, physicians and concerned citizens, and cites its mission as safeguarding health care from ideological threats.
'Do No Harm seeks to highlight and counteract divisive trends in medicine, such as 'Diversity, Equity and Inclusion' and youth-focused gender ideology,' the organization's website says.
According to the SPLC, Do No Harm in 2024 filed eight lawsuits challenging programs such as scholarships and fellowships for marginalized people.
'The group claims that the practice of nonprofit organizations like the American Association of University Women to provide fellowships to students of color and LGBTQ+ students — groups historically underrepresented in academia and medicine — harms patients by requiring medical schools to accept or fund unqualified candidates. According to the group, the case was dismissed 'after AAUW agreed to drop the racial criteria in the fellowship's selection process,'' the SPLC website says.
According to the website of Geisinger College of Health Sciences, it is the research and education arm of the Geisinger health system. Established in 2022, the college unifies the Geisinger Commonwealth School of Medicine, Geisinger School of Nursing, Geisinger School of Graduate Education, graduate medical education, Center for Faculty and Professional Development and more.
*
Geisinger College of Medicine in Scranton on Monday, June 9, 2025. (REBECCA PARTICKA/STAFF PHOTOGRAPHER)
*
Geisinger College of Medicine in Scranton on Monday, June 9, 2025. (REBECCA PARTICKA/STAFF PHOTOGRAPHER)
*
Geisinger College of Medicine in Scranton on Monday, June 9, 2025. (REBECCA PARTICKA/STAFF PHOTOGRAPHER)
Show Caption
1 of 3
Geisinger College of Medicine in Scranton on Monday, June 9, 2025. (REBECCA PARTICKA/STAFF PHOTOGRAPHER)
Expand
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
30 minutes ago
- Medscape
Family Ties May Shape Hashimoto Thyroiditis Risk
The odds of developing Hashimoto thyroiditis (HT) were significantly elevated in first-, second-, and third-degree relatives of patients with HT, with female relatives having a disproportionately higher likelihood. Of note, the odds of developing HT were elevated among spouses of patients. METHODOLOGY: Relatives of patients with HT are at an increased risk for HT; however, studies have primarily focused on first-degree relatives and often employed very small sample sizes. Researchers conducted a retrospective case-control study using genealogical and medical data from a Utah-based database (1996-2021) to estimate the risk for HT in relatives across various degrees of relatedness. They included 92,405 adult HT probands (73% women; 96% White individuals) and 184,810 matched control individuals, along with 2,960,650 first-, second-, and third-degree relatives of HT probands and 5,730,159 relatives of control individuals. TAKEAWAY: Relatives of patients with HT were at an increased risk for the condition, with the highest odds observed for first-degree relatives (odds ratio [OR], 1.77; 95% CI, 1.74-1.80), followed by second-degree (OR, 1.23; 95% CI, 1.22-1.27) and third-degree (OR, 1.11; 95% CI, 1.10-1.12) relatives. The risk for HT was an additional 2.2- to 2.6-fold higher in female relatives of patients with HT than overall estimates, across all degrees of relatedness. Among first-degree relatives, sons of men with HT had a markedly elevated risk for HT (OR, 2.36; 95% CI, 2.10-2.65). Wives of men with HT and husbands of women with HT were at an increased likelihood of developing HT, suggesting the effect of a shared environment. IN PRACTICE: 'These findings also have clinical implications, as understanding familial clustering of HT can help healthcare providers identify individuals at higher risk, especially those with affected FDRs [first-degree relatives]. This knowledge could lead to earlier monitoring and intervention, improving disease management,' the authors of the study wrote. SOURCE: This study was led by Melissa Bujnis, PhD, Department of Human Genetics, University of Utah, Salt Lake City. It was published online in The Journal of Clinical Endocrinology & Metabolism . LIMITATIONS: Reliance on diagnostic codes may have introduced misclassification bias, particularly in cases of transient hypothyroidism or misdiagnosed HT. Variations in diagnostic practices across clinics may have introduced heterogeneity in the sample. Individuals with a family history of HT might be more likely to receive diagnosis or seek medical attention, potentially introducing ascertainment bias. DISCLOSURES: Partial support for the datasets in the database was provided by the University of Utah, Huntsman Cancer Institute, National Institutes of Health (NIH). This study received support from NIH, NCRR, and Utah Department of Health and Human Services and the University of Utah. The authors reported no relevant conflicts of interest.
Associated Press
32 minutes ago
- Associated Press
Summit Spine Continues Expansion into North Carolina, Partners with Dr. Louis Torres
'We are thrilled to welcome Dr. Louis Torres to our team as we continue to enhance access to advanced pain care for the Fayetteville community.'— Dr. Amit Patel, CEO and Founder of Summit Spine & Joint Centers FAYETTEVILLE, NC, UNITED STATES, June 12, 2025 / / -- Summit Spine & Joint Centers, a leading multi-location provider of minimally invasive spine care, proudly announces the appointment of Dr. Louis Torres as the newest physician leader. Dr. Torres will support Summit's growing North Carolina operations – which operate under the Integrated Pain Solutions brand. Dr. Torres' arrival represents a strategic milestone in the organization's continued commitment to delivering best-in-class musculoskeletal (MSK) solutions to the Fayetteville region. With an established presence spanning 30 locations in Georgia, 11 in North Carolina, one in Tennessee, and two in South Carolina, Summit Spine & Joint Centers has earned widespread recognition for its excellence in pain management and compassionate patient care. The addition of Dr. Torres strengthens the Company's dedication to expanding access to high-quality, patient-focused care for individuals suffering from chronic pain across the Southeast. Specializing in the diagnosis and treatment of complex conditions—including neck and back pain, sciatica, herniated discs, headaches, pelvic and musculoskeletal pain, and neuropathic disorders—Summit Spine leverages state-of-the-art technologies to deliver precision-based care tailored to each patient's needs. 'We are thrilled to welcome Dr. Louis Torres to our team as we continue to enhance access to advanced pain care for the Fayetteville community,' said Dr. Amit Patel, CEO and Founder of Summit Spine & Joint Centers. 'Our team of highly skilled physicians, nurses, and support staff are united by a shared mission: to improve lives by relieving pain and restoring function through innovative, minimally invasive treatments.' Dr. Torres, a Fayetteville-based physician with strong ties to the region, shared his enthusiasm for the partnership: 'I'm honored to expand access to advanced pain care in a community that means so much to me. Summit's focus on cutting-edge technology and its collaborative, patient-centered approach ensures that each patient receives the highest level of comprehensive and compassionate care.' Summit Spine & Joint Centers operates 17 ASCs and 44 clinics across four (4) states, with Georgia locations in Athens, Augusta, Braselton, Buford, Canton, Carrollton, Cartersville, Columbus, Commerce, Conyers, Covington, Cumming, Dalton, Decatur, East Cobb, Gainesville, Jasper, Johns Creek/Norcross, Lawrenceville, Lithia Springs, Newnan, Ringgold/Ft. Oglethorpe, Rome, Roswell, Savannah, Snellville, Stockbridge, Stonecrest/Lithonia, Winder, and Woodstock; North Carolina clinics in Asheboro, Beaufort, Fayetteville, Jacksonville, Laurinburg (2), Rockingham, Southern Pines, Wadesboro, Whiteville, and Wilmington; clinics South Carolina locations in Greenville and Spartanburg; and a clinic in Chattanooga, Tennessee. For more information call (864) 383-0669 or visit Samantha Montague Summit Spine & Joint Centers +1 404-784-5318 email us here Visit us on social media: LinkedIn Instagram Facebook Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Yahoo
41 minutes ago
- Yahoo
HHS budget cuts threaten America's health and innovation—including in NC
(Photo courtesy of National Institutes of Health) By slashing nearly one-fourth of the Department of Health and Human Services (HHS) discretionary budget, the Trump administration's proposed fiscal year 2026 budget signals a dramatic retreat from evidence-based health research, disease prevention, and innovation. This $33.3 billion cut—to just under $95 billion—may be framed as a reorganization to tackle chronic disease and reduce healthcare costs, but beneath the rhetoric lies a troubling dismantling of the very infrastructure designed to advance public health, drive medical discovery, and protect our most vulnerable. Nowhere is the proposed rollback more alarming than in the realm of scientific research. The National Institutes of Health (NIH), the engine of U.S. biomedical innovation from which we all benefit, would see its funding slashed by $18 billion—from $45 billion to $27.5 billion—and its structure gutted, consolidating into just eight institutes or centers. Such a move ignores decades of bipartisan support for the NIH and undermines the United States' global leadership in medical research. These cuts will decelerate clinical trials, delay therapies, and disincentivize young scientists from entering the field. The American Cancer Society Cancer Action Network warns that the 37% cut to the National Cancer Institute would 'stall scientific breakthroughs' and hamper efforts against the increasing incidence of cancer across America. Translation: lives will be lost waiting for discoveries that now may never happen. The effects of these cuts will be especially devastating in states like North Carolina, a national leader in biomedical research, academic medicine, and public health innovation. Institutions such as Duke University, the University of North Carolina at Chapel Hill, Wake Forest, and East Carolina University receive hundreds of millions annually from NIH and HHS to fund research on everything from cancer to mental health to rural healthcare delivery. If these funding sources dry up or diminish, North Carolina's research infrastructure—its labs, its jobs, and its ability to develop life-saving treatments—will likely suffer. In 2022 alone, North Carolina institutions received over $1.8 billion in NIH funding. These dollars supported everything from HIV prevention programs in underserved areas to groundbreaking cancer immunotherapy research. The University of North Carolina's Gillings School of Global Public Health, which has led critical studies on pandemic response and maternal health, faces a direct threat under these budget proposals. And Duke's renowned Clinical and Translational Science Institute, which works to turn research into real-world healthcare solutions, would likely struggle to maintain operations at current levels. Beyond academic campuses, the proposed cuts threaten North Carolina's community health centers, rural hospitals, and telehealth programs—many of which rely on HHS grants to reach underserved populations. The elimination of key funding for CDC public health initiatives and the Affordable Care Act's Prevention and Public Health Fund will hit rural counties the hardest, where high rates of chronic illness and limited access to care demand more investment, not less. The proposed budget does include some provocative titles—like the $500 million 'Make America Healthy Again' initiative—but these piecemeal programs offer a fraction of the scale needed to address national health challenges. Only $119 million is allocated for a Prevention Innovation program, while over $1.5 billion in HIV prevention programs are being slashed. North Carolina, which continues to fight high rates of HIV, will feel the consequences firsthand. Innovation is not just about profit or prestige—it's about people. Patients waiting for a clinical trial in Charlotte, veterans accessing mental health support through telehealth in western North Carolina, and community health workers in rural eastern North Carolina trying to curb diabetes rates. These are the real faces behind the numbers. Congress now holds the line. It must reject this dangerous budget, reinvest in science and health equity, and protect the institutions that allow America—and North Carolina—not just to respond to crises, but prevent them. Innovation cannot survive on slogans. It thrives on sustained, strategic, and science-driven investment. Anything less is not just shortsighted—it's reckless.
